UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
1984, ISBN 030641547X, Volume 5, xviii, 351
Book
World neurosurgery, ISSN 1878-8750, 08/2019, Volume 128, pp. 448 - 451
Surgical resection | Radiotherapy | Surgical seeding | Scalp metastasis | Anaplastic oligodendroglioma | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Surgery | Science & Technology | Skin Neoplasms - pathology | Skin Neoplasms - diagnostic imaging | Head and Neck Neoplasms - secondary | Oligodendroglioma - surgery | Scalp - surgery | Scalp - diagnostic imaging | Head and Neck Neoplasms - diagnostic imaging | Humans | Brain Neoplasms - pathology | Oligodendroglioma - secondary | Head and Neck Neoplasms - pathology | Oligodendroglioma - pathology | Scalp - pathology | Brain Neoplasms - therapy | Skin Neoplasms - secondary | Adult | Female | Radiotherapy, Adjuvant | Skin Neoplasms - surgery | Head and Neck Neoplasms - surgery | Oligodendroglioma - diagnostic imaging | Medicine, Experimental | Medical research | Relapse | Metastasis | World health | Diseases | Index Medicus
Journal Article
Journal of neurosciences in rural practice, ISSN 0976-3147, 09/2012, Volume 3, Issue 3, pp. 379 - 382
Journal Article
Neurologic clinics, ISSN 0733-8619, 08/2018, Volume 36, Issue 3, pp. 467 - 484
PCV | Temozolomide | IDH | 1p/19q codeletion | Anaplastic | Astrocytoma | Bevacizumab | Oligodendroglioma | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Astrocytoma - genetics | Oligodendroglioma - genetics | Brain Neoplasms - classification | Brain Neoplasms - diagnosis | Humans | Oligodendroglioma - diagnosis | Brain Neoplasms - genetics | Astrocytoma - classification | Oligodendroglioma - classification
Journal Article
Neuro-oncology (Charlottesville, Va.), ISSN 1522-8517, 10/2016, Volume 18, Issue suppl_4, pp. iv53 - iv53
Journal Article
Cancer, ISSN 0008-543X, 04/2009, Volume 115, Issue 8, pp. 1734 - 1743
bevacizumab | alkylator | refractory | recurrent anaplastic oligodendroglioma | chemotherapy | Recurrent anaplastic oligodendroglioma | Refractory | Chemotherapy | Alkylator | Bevacizumab | Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Tumors | Oligodendroglioma - genetics | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Drug Resistance, Neoplasm | Male | Brain Neoplasms - drug therapy | Antineoplastic Agents, Alkylating - therapeutic use | Antibodies, Monoclonal, Humanized | Disease-Free Survival | Chromosomes, Human, Pair 1 | Astrocytoma - drug therapy | Survival Analysis | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Retrospective Studies | Oligodendroglioma - drug therapy | Gliomas | Care and treatment | Research | Index Medicus | Abridged Index Medicus
Journal Article
Frontiers in oncology, ISSN 2234-943X, 12/2019, Volume 9, pp. 1371 - 1371
Journal Article
Neuro-oncology (Charlottesville, Va.), ISSN 1522-8517, 07/2007, Volume 9, Issue 3, pp. 314 - 318
Molecular genetic studies | Treatment recommendations | Survey | 19q | Temozolomide | Radiotherapy | Anaplastic oligodendroglioma | Oncology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Oligodendroglioma - genetics | Brain Neoplasms - diagnosis | Humans | Oligodendroglioma - diagnosis | Brain Neoplasms - genetics | Antineoplastic Agents - therapeutic use | Combined Modality Therapy | Data Collection | Practice Patterns, Physicians | Molecular Biology - trends | Oligodendroglioma - therapy | Brain Neoplasms - therapy | Index Medicus | temozolomide | Clinical Investigations | radiotherapy | survey | molecular genetic studies | anaplastic oligodendroglioma | treatment recommendations
Journal Article
Current treatment options in oncology, ISSN 1527-2729, 12/2013, Volume 14, Issue 4, pp. 505 - 513
Chemotherapy | Medicine & Public Health | Irradiation | Oncology | Procarbazine, lomustine and vincristin | Temozolomide | Anaplastic oligodendroglioma | Life Sciences & Biomedicine | Science & Technology | Procarbazine - administration & dosage | Oligodendroglioma - mortality | Oligodendroglioma - genetics | Humans | Lomustine - adverse effects | Radiotherapy, High-Energy | Brain Neoplasms - genetics | Male | Combined Modality Therapy | Patient Selection | Oligodendroglioma - therapy | Procarbazine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Gene Deletion | Brain Neoplasms - therapy | Survival Analysis | Quality of Life | Vincristine - administration & dosage | Vincristine - adverse effects | Female | Brain Neoplasms - mortality | Lomustine - administration & dosage | Care and treatment | Usage | Reports | Forecasts and trends | Radiotherapy | Oligodendroglioma | Cancer | Index Medicus
Journal Article
Journal of neurosurgery, ISSN 0022-3085, 10/2016, Volume 125, Issue 4, pp. 995 - 1001
Angiogenesis | Oncology | Prognosis | 1p/19q | Anaplastic oligodendroglioma | Endothelial cells | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Surgery | Science & Technology | Chromosome Deletion | Endothelial Cells | Oligodendroglioma - genetics | Humans | Middle Aged | Brain Neoplasms - genetics | Male | Young Adult | Chromosome Aberrations | Adult | Female | Chromosomes, Human, Pair 1 - genetics | Index Medicus | Abridged Index Medicus
Journal Article
Pediatric blood & cancer, ISSN 1545-5009, 06/2017, Volume 64, Issue 6, p. n/a
NF1 | precision medicine | fibroblast growth factor receptor type 1 | molecular sequence data | spinal cord neoplasms | anaplastic oligodendroglioma | Oligodendroglioma - genetics | Neoplasm Proteins - biosynthesis | Spinal Neoplasms - diagnostic imaging | Humans | Transcriptome | Child, Preschool | Receptor, Fibroblast Growth Factor, Type 1 - genetics | Exome | Gene Deletion | Spinal Neoplasms - genetics | Oligodendroglioma - metabolism | Spinal Neoplasms - metabolism | Female | Neoplasm Proteins - genetics | Neurofibromin 1 - genetics | Neurofibromin 1 - biosynthesis | Oligodendroglioma - diagnostic imaging | Receptor, Fibroblast Growth Factor, Type 1 - biosynthesis | Index Medicus
Journal Article
2016, ISBN 0128029978, Volume 134
temozolomide | PCV | oligodendroglioma | anaplastic | TERT | oligoastrocytoma | 19q | IDH | 1p | Oligoastrocytoma | Temozolomide | Anaplastic | Oligodendroglioma | Oligodendroglioma - genetics | Dacarbazine - therapeutic use | Humans | DNA Repair Enzymes - genetics | Brain Neoplasms - genetics | Isocitrate Dehydrogenase - genetics | Antineoplastic Agents - therapeutic use | Mutation - genetics | DNA Modification Methylases - genetics | Oligodendroglioma - therapy | Procarbazine - therapeutic use | Chemotherapy, Adjuvant - methods | Tumor Suppressor Proteins - genetics | Brain Neoplasms - therapy | Dacarbazine - analogs & derivatives | Vincristine - therapeutic use | Index Medicus
Book Chapter
Journal of neuro-oncology, ISSN 0167-594X, 2014, Volume 116, Issue 1, pp. 161 - 168
Neurology | Anaplastic oligoastrocytoma | Medicine & Public Health | Cognitive functioning | Oncology | Anaplastic oligodendroglioma | Quality of life | Astrocytoma - therapy | Brain Neoplasms - psychology | Dacarbazine - therapeutic use | Humans | Middle Aged | Male | Brain Neoplasms - complications | DNA Repair Enzymes | Radiotherapy | Astrocytoma - complications | Neuropsychological Tests | Cognition Disorders - etiology | DNA Modification Methylases | Brain Neoplasms - therapy | Dacarbazine - analogs & derivatives | Statistics, Nonparametric | Quality of Life | Female | Aged | Astrocytoma - psychology | Survivors - psychology | Health Status | Tumor Suppressor Proteins | Cohort Studies | Chemotherapy | Cancer | Index Medicus | Brain
Journal Article
Cancer management and research, ISSN 1179-1322, 07/2015, Volume 7, pp. 213 - 223
Molecular markers | Chemotherapy | Treatments toxicity | Radiotherapy | Anaplastic oligodendroglioma | Life Sciences & Biomedicine | Oncology | Science & Technology | Care and treatment | Oncology, Experimental | Development and progression | Research | Biological markers | Identification and classification | Health aspects | Oligodendroglioma | Cancer | Lung cancer | Epilepsy | Brain cancer | Systematic review | Radiation therapy | Patients | Cancer therapies | Quality of life | Convulsions & seizures | Medical prognosis | Mutation | Age | Tumors
Journal Article
Journal of neuro-oncology, ISSN 0167-594X, 01/2014, Volume 116, Issue 1, pp. 161 - 168
FOLLOW-UP | MALIGNANT BRAIN-TUMORS | CANCER | Anaplastic oligodendroglioma | CHEMOTHERAPY | Quality of life | PHASE-III TRIAL | Anaplastic oligoastrocytoma | ADJUVANT PROCARBAZINE | GLIOBLASTOMA | Cognitive functioning | QUESTIONNAIRES | EUROPEAN-ORGANIZATION | HIGH-GRADE GLIOMA | Oncology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology
Journal Article